143 related articles for article (PubMed ID: 2908595)
21. Detection of minimal disease in patients with solid tumors.
Pantel K
J Hematother; 1996 Aug; 5(4):359-67. PubMed ID: 8877711
[TBL] [Abstract][Full Text] [Related]
22. Biochemical and immunologic diagnosis of cancer. Leukemia and lymphoma.
Shiku H
Tumour Biol; 1987; 8(2-3):156-60. PubMed ID: 3329399
[No Abstract] [Full Text] [Related]
23. [Minimal residual disease in leukemia].
Morishima Y
Gan To Kagaku Ryoho; 1991 Sep; 18(12):2063-9. PubMed ID: 1888177
[TBL] [Abstract][Full Text] [Related]
24. Clinical studies of autografting in acute lymphocytic leukaemia.
Dicke KA; Spitzer G
Clin Haematol; 1986 Feb; 15(1):85-103. PubMed ID: 2938864
[TBL] [Abstract][Full Text] [Related]
25. Expression of CD10, CD19 and CD34 markers in bone marrow samples of children with precursor B-cell acute lymphoblastic leukemia in clinical and hematological remission.
Cáp J; Babusíková O; Kaiserová E; Jamárik M
Neoplasma; 1998; 45(4):231-6. PubMed ID: 9890666
[TBL] [Abstract][Full Text] [Related]
26. Characterization of hematologic malignancies by flow cytometry.
Barlogie B; Latreille J; Freireich EJ; Fu CT; Mellard D; Meistrich M; Andreeff M
Blood Cells; 1980; 6(4):719-44. PubMed ID: 7008871
[TBL] [Abstract][Full Text] [Related]
27. [Advance in treatments of leukemia following the new concept of pathophysiology].
Hirashima K
Nihon Naika Gakkai Zasshi; 1988 Sep; 77(9):1367-72. PubMed ID: 3073173
[No Abstract] [Full Text] [Related]
28. Abnormal in vitro differentiation of clonogenic B-cells in common acute lymphoblastic leukemia in complete remission. A marker for minimal residual disease?
Bréard J; Mathé G; Consolini R
Bull Soc Sci Med Grand Duche Luxemb; 1989; 126(1):47-50. PubMed ID: 2525967
[TBL] [Abstract][Full Text] [Related]
29. Intercellular variation in the amounts of DNA, RNA and mass in a leukemia and a fibroblast cell population in vitro.
Killander D
Eur J Cancer (1965); 1967 Nov; 3(4):309-14. PubMed ID: 6078930
[No Abstract] [Full Text] [Related]
30. Allogeneic marrow transplantation in children with acute leukemia: careful comparison with chemotherapy alternatives required.
Pulsipher MA; Hunger SP; Gamis AS; Wall DA; Grupp SA
Leukemia; 2010 Jun; 24(6):1212-6. PubMed ID: 20428198
[No Abstract] [Full Text] [Related]
31. Acute leukemia coexpressing myeloid, B- and T-lineage associated markers: multiparameter analysis of criteria defining lineage commitment and maturational stage in a case of undifferentiated leukemia.
Meckenstock G; Heyll A; Schneider EM; Hildebrandt B; Runde V; Aul C; Bartram CR; Ludwig WD; Schneider W
Leukemia; 1995 Feb; 9(2):260-4. PubMed ID: 7869761
[TBL] [Abstract][Full Text] [Related]
32. Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195.
Jurcic JG; Caron PC; Miller WH; Yao TJ; Maslak P; Finn RD; Larson SM; Warrell RP; Scheinberg DA
Leukemia; 1995 Feb; 9(2):244-8. PubMed ID: 7869759
[TBL] [Abstract][Full Text] [Related]
33. Flow cytometric analysis of cell-surface and intracellular antigens in the diagnosis of acute leukemia.
Paredes-Aguilera R; Romero-Guzman L; Lopez-Santiago N; Burbano-Ceron L; Camacho-Del Monte O; Nieto-Martinez S
Am J Hematol; 2001 Oct; 68(2):69-74. PubMed ID: 11559944
[TBL] [Abstract][Full Text] [Related]
34. Acute leukemia with extramedullary presentation and mixed myeloid and lymphoid expression.
Bayle C; Romdhane NB; Bastard C; Vannier JP; Hayat M; Lemerle J; Bernard A
Pediatr Hematol Oncol; 1986; 3(3):293-6. PubMed ID: 3153242
[No Abstract] [Full Text] [Related]
35. [In vitro treatment of leukemic bone marrow. What future for autologous bone marrow transplantation?].
Gorin NC
Presse Med; 1984 May; 13(21):1325-9. PubMed ID: 6233554
[TBL] [Abstract][Full Text] [Related]
36. [Autograft of bone marrow for the treatment of acute leukemia: in vitro efficacy of anti-leukemic purification].
Gorin NC; Salmon C; Duhamel G
Ann Med Interne (Paris); 1986; 137(2):92-9. PubMed ID: 3521433
[TBL] [Abstract][Full Text] [Related]
37. Immunologic approaches to the classification of non-Hodgkin's lymphomas.
Grogan TM; Spier CM; Richter LC; Rangel CS
Cancer Treat Res; 1988; 38():31-148. PubMed ID: 2908600
[No Abstract] [Full Text] [Related]
38. Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia.
Roberts WM; Estrov Z; Ouspenskaia MV; Johnston DA; McClain KL; Zipf TF
N Engl J Med; 1997 Jan; 336(5):317-23. PubMed ID: 9011783
[TBL] [Abstract][Full Text] [Related]
39. Clinical review on features and cytogenetic patterns in adult acute myeloid leukemia with lymphoid markers.
Cuneo A; Ferrant A; Michaux JL; Boogaerts M; Demuynck H; Bosly A; Doyen C; Carli MG; Piva N; Castoldi G
Leuk Lymphoma; 1993 Mar; 9(4-5):285-91. PubMed ID: 8348065
[TBL] [Abstract][Full Text] [Related]
40. Monoclonal antibody-ricin conjugate cytotoxic to cells expressing the common acute lymphoblastic leukemia antigen (CALLA).
Pelham JM; Meyer BF; Herrmann RP; Davis RE; Raphael CL; Kraft N; Atkins RC
Pathology; 1987 Apr; 19(2):124-30. PubMed ID: 2969499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
